Hannah Anderson, Postdoctoral Fellow, Moffitt
Research Projects:
"Optimization of TIL therapies in bladder tumors"
joint project with experimental lab of Shari Pilon-Thomas and
clinical group of Michael Poch, Moffitt
![]() |
![]() |
IMO Research-in-Progress (RIP) seminar, November 18th 2025, presentation: "Evaluating Robustness of an Optimized Regimen in a Virtual Murine Cohort of Bladder Cancer"
![]()
![]() |
MathOnco25 -- 2025 Mathematical Oncology meeting, October 28-31st 2025, St. Pete, Florida, contributed podium presentation: "A framework for developing a virtual murine cohort: applications to adoptive cell therapy in bladder cancer"
![]()
![]() |
![]() |
2025 Annual meeting of the Society for Mathematical Biology (SMB), July 13-18th 2025, Edmonton, Canada, organized a minisymposium "Advances in Optimal Control Methods for Diverse Modeling Frameworks" and presented a podium talk "Optimal control of adoptive T-cell therapy and gemcitabine in non-muscle invasive bladder cancer"
![]()
![]() |
![]() |
![]() |
2025 Moffitt Scientific Symposium, May 13th 2025, the Best Poster Award in Quantitative Science Division for a poster: "Virtual Murine Cohort for OT-1 Cells in Combinations with Gemcitabine in Bladder Cancer Treatment"
![]()